News

Merck Manuals is launching a new artificial intelligence-powered search tool designed to provide patients with streamlined access to trusted information and resources from its medical manuals.
Merck & Co., Inc. (NYSE:MRK) is one of the 15 best stocks to invest in for an 18 year old. On June 10, Cantor Fitzgerald reaffirmed its Neutral rating on Merck & Co., Inc. (NYSE:MRK) with a fixed ...
There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could be a steal of a deal.(Seth Wenig / AP) Shares of pharmaceutical ...
Today, we meet Doina Ionescu, general manager of the healthcare division at Merck. Raised in Romania, the 56-year-old joined the Fortune 500 pharmaceutical giant, Merck, after being personally ...
CareTrust, Merck, and Allete have rewarded shareholders for years and recently announced dividend increases. These companies ... Shareholders of Merck would probably like to forget the past six ...
Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion. The acquisition – which was confirmed to be in the final stages ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout ...
Merck has traditionally eschewed large-scale M&A, but has been warming to the concept in recent years, with deals including its $11.5 billion takeover of Acceleron last year and its $2.75 billion ...
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Merck, a leading science and technology company, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 American Society of Clinical Oncology (ASCO ...